New compound shows promise as a more effective treatment for schistosomiasis

A newly developed compound is showing promise in animal studies as a more effective treatment for human schistosomiasis, an understudied tropical disease caused by parasitic worms.

Incannex Healthcare Announces Completion of its Redomiciliation to the United States | Psychedelic Invest

Incannex Healthcare Inc. (NASDAQ: IXHL) is pleased to announce that its previously announced transaction to redomicile Incannex Healthcare from Australia to the United States has

November 30, 2023

Ethanolic extracts from olive leaves show promise in combating cancer and infections

A recent study in Antioxidants reveals that ethanolic extracts from Greek and Spanish olive leaves exhibit high antioxidant, antimicrobial, and anticancer properties, with Greek extracts

July 1, 2024

FDA approves Luye Pharma’s ERZOFRI for schizophrenia

Schizophrenia and schizoaffective disorder are severe, chronic psychiatric conditions that often result in relapses. Credit: Doidam 10 / Shutterstock. The US Food and Drug Administration

July 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.